From scientific discoveries to promising clinical trials, City of Hope constantly advances new and better ways to improve the lives of people here and throughout the world.
You can find the latest information on our research, clinical and educational programs through this listing of current press releases.
Legendary music executive Clive Davis, singer/songwriter Burt Bacharach, contemporary music artist Charli XCX and film composer Christophe Beck (“Frozen”), along with top music and entertainment industry VIPs, will come together at the 11th annual Songs of Hope to celebrate the song and songwriter, and to raise funds for lifesaving cancer research at City of Hope.
City of Hope and Fortress Biotech have reached an agreement to form a new subsidiary company, DiaVax Biosciences, that will develop two novel vaccines against cytomegalovirus (CMV) infection, a life-threatening illness in people with weakened or underdeveloped immune systems, such as cancer patients and developing fetuses.
A Los Angeles teen looking forward to wrapping up her sophomore year in high school and a West Point graduate who is now president of his own financial company have never met, but they have more in common than they would otherwise imagine.
City of Hope today announced it has been named a final awardee and will receive funding from the Institute for Healthcare Improvement (IHI) to support promising community-based work on health improvement, as part of the SCALE (Spreading Community Accelerators through Learning and Evaluation) initiative.
City of Hope today announced it has been named a finalist in the running to receive funding from the Institute for Healthcare Improvement (IHI) to become a leading community on health improvement, as part of an initiative known as SCALE (Spreading Community Accelerators through Learning and Evaluation).
In the field of cancer, patients have had surgery, chemotherapy and radiation therapy as options. Now, as City of Hope officially opens the Alpha Clinic for Cell Therapy and Innovation, patients battling cancer and other life-threatening diseases have another option: stem cell-based therapy.
Acclaimed translational research scientist and physician Larry W. Kwak, M.D., Ph.D., will join City of Hope in a key leadership role within the institution’s new Hematologic Malignancies and Stem Cell Transplantation Institute. As director of the Toni Stephenson Lymphoma Center, Kwak will shape the next generation of research and treatments for all types of lymphoma.
The California Institute of Regenerative Medicine has awarded City of Hope researchers a significant grant to help address a problem currently creating a bottleneck in stem cell research: The lack of a scalable and practical way to produce and store enough stem cells for therapies and clinical trials on a larger scale.
City of Hope’s National Professional Salon Industry Group will honor Steve Goddard, president and founder of PRAVANA, with its 2015 Spirit of Life® Award.
Renowned physician and researcher Guido Marcucci has joined City of Hope in a key leadership role within the institution’s new Hematologic Malignancies and Stem Cell Transplantation Institute.
Accomplished philanthropic leader Kristin Bertell is joining City of Hope in the role of chief philanthropy officer. Currently associate vice chancellor of health sciences development at UC San Diego, Bertell will provide executive and strategic oversight for all aspects of City of Hope’s philanthropic efforts as the cancer treatment center and biomedical research institution enters a new era of growth and development.
A new standard of care for HIV-associated lymphoma, promising news for patients with relapsing or treatment-resistant lymphoma, and immunotherapy approaches to treating hematologic cancers are among the breakthroughs City of Hope scientists will share at the American Society of Hematology meeting.
Results from a multicenter clinical trial could knock down barriers to autologous stem cell transplants for patients with HIV-associated lymphoma, currently the standard of care for some non-HIV infected patients.
On Jan. 1, for the 42nd year, cancer research and treatment center City of Hope will participate in the 126th Tournament of Roses Parade. This year, they’ll be joined by five families celebrating their futures – futures they wouldn’t have had without City of Hope.
City of Hope has again gained recognition for its excellence in quality care by perhaps the most meaningful measure of all: patient satisfaction. Positive patient feedback has earned City of Hope its sixth consecutive Press Ganey Guardian of Excellence Award.
Physicians and scientists at the Hematologic Malignancies and Stem Cell Transplantation Institute are using T cell therapy against blood cancers and other diseases.
A new vaccine strategy can potentially prevent a viral infection that causes 5,000 babies yearly to be born with permanent disabilities.
A new agreement between City of Hope and California Institute of Technology will foster greater collaboration between some of the most innovative thinkers in technology, medicine and science.
City of Hope continues its longstanding commitment to combating diabetes, a leading national and global health threat, with a $60 million investment to expand basic and translational research efforts through its new Diabetes & Metabolism Research Institute.
Identifying cures for currently incurable diseases and providing patients safe, fast, and potentially life-saving treatments is the focus of City of Hope’s new Alpha Clinic for Cell Therapy and Innovation (ACT-I).
Even with the best possible management, type 1 diabetes negatively impacts health, lifespan and quality of life for the millions of people worldwide who have the disease. Two City of Hope researchers working to change that bleak outlook have recently received some significant help from the National Institutes of Health. Together, they’ve been awarded two grants totaling nearly $7.5 million to support their research into type 1 diabetes.
Cancers of the blood and immune system are considered to be among the most difficult-to-treat cancers. A world leader in the treatment of blood cancers, City of Hope is now launching an institute specifically focused on researching and treating lymphoma, leukemia and myeloma, as well as other serious blood and bone marrow diseases.
City of Hope announces two important developments in the leadership team of its world-renowned Comprehensive Cancer Center: Linda Malkas, Ph.D., will expand her role as deputy director of basic research, and Matthew Ruchin, formerly of Northwestern University’s Robert H. Lurie Comprehensive Cancer Center, will join City of Hope’s center as its associate director.
Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Institute.
Nationally respected marketing, branding and management expert Lisa Stockmon is joining City of Hope in the new role of chief marketing and communications officer. Stockmon will provide the overall strategic leadership for City of Hope marketing and communications initiatives as the cancer treatment center and biomedical research institution enters a new era of growth and development.
City of Hope and Wilshire Oncology Medical Group have reached an agreement in which Wilshire physicians will join City of Hope Medical Group, delivering care to patients through City of Hope’s new community practice sites in Glendora, Pomona, Rancho Cucamonga, West Covina and Corona.
A $2.5 million gift from the Panda Charitable Foundation will help launch the Program in Natural Therapies at City of Hope, helping researchers investigate the potential of foods and other plant-based ingredients to fight disease.
Specialized high school educational programs that fast-track students to jobs by providing college-level training and career readiness are heralded as the next revolution in education.
A new approach to treating HIV could free patients from the virus’s tyranny for once and for all. The approach will now advance to clinical trials through a $5.6 million grant from the California Regenerative Medicine Institute awarded to a team led by City of Hope.
Cue will be the first honoree from the technology sector, an acknowledgment of the exciting ways technology and entertainment now intersect to enhance the consumer experience. The award will be presented at a gala dinner in Los Angeles on Oct. 23.
The clinic, located next to Methodist Hospital of Southern California, will increase the availability of City of Hope’s renowned cancer specialists within the Arcadia community and will provide additional convenience for patients seeking general oncologic surgery and medical oncology services.
City of Hope researchers report on young adult cancer patients, location of cancer care, medication nonadherence and phase II drug trials of XL184 (cabozantinib) for breast cancer and ABT-888 (veliparib) for lung cancer.
Bone marrow transplants offer a second chance for people with life-threatening blood cancers and other hematologic malignancies. But many recipients, though overwhelmed with curiosity and the need to express their gratitude, can only dream of meeting the strangers who saved their lives. City of Hope is about to make that dream come true for two patients.
The funding, made possible by philanthropic support, will be used to recruit highly experienced and well-published scientists to join the Department of Diabetes and Metabolic Diseases Research at Beckman Research Institute of City of Hope. Their areas of research will include cell biology, immunology, diabetic complications, gene regulation and obesity
A burglary that occurred on Feb. 5, 2014, at Sutherland Healthcare Solutions’ office in Torrance resulted in the theft of eight computers, two of which contained personal information about a small percentage of City of Hope patients and their financial guarantors. Sutherland is an outside vendor that contracts with health care providers, including City of Hope, for certain billing services.
Yuman Fong, M.D., an internationally recognized expert in hepatobiliary cancer and in the use of genetically modified viruses to combat malignant disease, has been named chair of the Department of Surgery at City of Hope.
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds’ effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
Five foundations — Alex’s Lemonade Stand Foundation, Pediatric Cancer Research Foundation (PCRF), The Matthew Larson Foundation for Pediatric Brain Tumors — and two anonymous foundations have announced grants totaling $450,000 in support of Dr. Margarita Gutova’s work, allowing her to continue her preclinical studies using neural stem cells to treat medulloblastoma.
Noted business leader and physician Norman C. Payson, M.D., has been selected as the new chair of the City of Hope board of directors. He began his three-year term on Jan. 1, taking helm of the institution’s board as the research and treatment center launches a new era of growth and scientific investment.
A team of City of Hope researchers has received a two-year, $1 million Movember-Prostate Cancer Foundation (PCF) Challenge Award for a double-armed project to treat advanced prostate cancer. The team will be studying two novel agents’ promising ability to stage a combined immunotherapeutic attack against prostate cancer cells, which have previously been resistant to such an effort.
A $10 million gift from Internet-publishing entrepreneurs Emmet and Toni Stephenson and their daughter Tessa Stephenson Brand will fund the creation of the Toni Stephenson Lymphoma Center at City of Hope, the cornerstone of the institution’s new Hematologic Malignancies Institute.
City of Hope and Methodist Hospital of Southern California have reached an agreement in which City of Hope will acquire the hospital’s radiation oncology service in Arcadia. The acquisition will expand access to City of Hope’s renowned expertise in radiation therapy and will provide additional convenience for patients seeking specialized cancer services.
Prestigious Press Ganey awards honor institutions for outstanding patient satisfaction
City of Hope has earned two prestigious Press Ganey awards for its top-quality patient care, marking its fifth consecutive year of being honored by the healthcare industry’s leading performance improvement firm.
State-of-the-art facility will bring top-level, comprehensive care to the region’s cancer patients
Understanding that innovation and inclusion are vital to an effective partnership with our patients and the community at large, City of Hope is proud to announce the launch of a Chinese-language website, cn.cityofhope.org
, with content focused specifically on the needs of Chinese-speaking patients, caregivers and their families.
Rosen, an internationally known specialist in hematologic malignancies, will set the scientific direction of City of Hope as it embarks on a new era of strategic growth, shaping the research and educational vision for the $1.2-billion independent biomedical research, treatment and education institution.
City of Hope and Providence Health & Services, Southern California, announced today their intent to expand access to uniquely compassionate, high-quality oncology services within the Southern California communities served by Providence.
A $6.25 million gift from the estate of Billy and Audrey L. Wilder will be used to create two professorships for City of Hope researchers, along with the Wilder Archives Recognition Gallery at City of Hope.
The 2013-2014 edition of U.S.News & World Report’s “Best Hospitals” has listed City of Hope as one of the best cancer hospitals in the nation. This marks the tenth year that City of Hope has appeared in the cancer rankings of the “Best Hospitals” report, which recognizes elite hospitals in the U.S.
City of Hope has been notified of the renewal of the prestigious comprehensive cancer center designation from the National Cancer Institute (NCI), a milestone that marks the institution’s 30th year with an NCI designation.
The event will pit longtime rival teams Grand Ole Opry and “After MidNite with Blair Garner” against each other on Saturday, June 8, at 9 a.m. at Greer Stadium.
The therapy works through a two-part process that simultaneously takes apart the tumors’ support network while stimulating the immune system to attack the cancerous cells.
The pledge, which will be used to enhance the scientific core and capacity of City of Hope’s Diabetes Research Center by recruiting a nationally acclaimed leader in the field of diabetes research, was given in honor of Annette and Leonard Shapiro, longtime friends and supporters of groundbreaking diabetes research and of City of Hope.
Members of those chapters will be celebrating their contributions to City of Hope, a National Cancer Institute-designated comprehensive cancer center, at a truly unique luncheon on May 5, 2013 at Glendale Country Club in Bellevue, Wash.
City of Hope, Antelope Valley Hospital, and G. L. Bruno Associates Inc. celebrated the completion of the internal structure of City of Hope | Antelope Valley with a “topping off” ceremony on Friday, April 12, 2013.
The Harrows will receive their awards at the West Coast Golf & Tennis Tournament on June 10, 2013 at the Coto de Caza Golf and Racquet Club in Coto de Caza, CA. For more information about the event, please contact Yolanda V. Guerrero at 800-272-2310 or email@example.com
or log on to the event website at www.cityofhope.org/nhfi/tournament
A former executive vice president at WellPoint Inc., overseeing Comprehensive Health Solutions, Levine will lead the medical foundation in its mission to care for, and provide services to, City of Hope patients.
City of Hope has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s extraordinary commitment to the health of its employees and their families.